查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
亚太地区 dPCR 和 qPCR 市场预测至 2030 年 - 区域分析 - 按治疗、产品、应用和最终用户
市场调查报告书
商品编码
1494309

亚太地区 dPCR 和 qPCR 市场预测至 2030 年 - 区域分析 - 按治疗、产品、应用和最终用户

Asia Pacific dPCR and qPCR Market Forecast to 2030 - Regional Analysis - By Treatment, Product, Application, and End User
出版日期: | 出版商: The Insight Partners | 英文 105 Pages | 订单完成后即时交付

价格

2022年亚太地区dPCR和qPCR市值为19.1343亿美元，预计2030年将达到41.395亿美元；预计2022年至2030年复合年增长率为10.1%。

PCR 技术的进步推动亚太地区 dPCR 和 qPCR 市场

聚合酶炼式反应(PCR) 是一种几乎无所不在、强大且可靠的技术，大多数分子生物学实验室都使用它来扩增特定的DNA 片段，以进行基因分型、克隆和单核苷酸变异分析，甚至可以作为大多数下一代技术的基础定序（NGS）准备。技术进步催生了不同类型的 PCR 技术。 PCR 技术的使用现已探索到多种非常规应用，使分子诊断变得更容易、更快捷。特别是，数位和即时 PCR 的进步可用于诊断疾病、识别病毒和细菌以及协助法医调查。此外，研究人员正在尝试使用一些奈米材料来减少测试时间。 2023 年 3 月，韩国科学技术院智慧感测增强安全系统中心（KIST，院长：Seok Jin Yoon）宣布，Sang Kyung Kim 博士（主任）和郑胜元的研究团队。与先前利用光热奈米材料进行的测试相比，超快速PCR将测试时间缩短了十倍。新方法的诊断效能与目前的测试方法相当，并且可以在5分钟内完成。因此，PCR 技术的进步推动了亚太地区 dPCR 和 qPCR 市场的成长。

亚太地区 dPCR 和 qPCR 市场概览

亚太地区的 dPCR 和 qPCR 市场分为中国、日本、印度、韩国、澳洲和亚太其他地区。中国、印度和日本是市场成长的三个主要贡献者，这些国家的外国直接投资不断增加，高技能、高效和大量的劳动力，以及精简的政府政策导致生物技术领域的高投资。此外，传染病和慢性病病例的增加以及政府和非政府措施也推动了亚太地区 dPCR 和 qPCR 市场的成长。

亚太地区 dPCR 和 qPCR 市场收入及 2030 年预测（百万美元）

亚太地区 dPCR 和 qPCR 市场细分

亚太地区 dPCR 和 qPCR 市场根据治疗、产品、应用、最终用户和国家进行细分。

根据处理方式，亚太地区 dPCR 和 qPCR 市场分为定量 PCR (qPCR) 和数位 PCR (dPCR)。到 2022 年，数位 PCR (dPCR) 领域将占据更大的份额。

依产品划分，亚太地区 dPCR 和 qPCR 市场分为试剂和耗材、仪器以及软体和服务。 2022 年，试剂和耗材领域占最大份额。

依应用划分，亚太地区 dPCR 和 qPCR 市场分为研究应用、临床应用和法医应用。 2022年，临床应用领域占据最大份额。

按最终用户划分，亚太地区 dPCR 和 qPCR 市场分为医院和诊断中心、製药和生物技术公司、研究实验室和学术机构、法医实验室以及临床研究组织。 2022 年，医院和诊断中心细分市场占据最大份额。

依国家/地区划分，亚太地区 dPCR 和 qPCR 市场分为中国、日本、印度、澳洲、韩国和亚太地区其他地区。 2022 年，中国在亚太地区 dPCR 和 qPCR 市场占据主导地位。

Abbott Laboratories、Thermo Fisher Scientific Inc、Takara Bio Inc、Genome Diagnostics Pvt Ltd、Qiagen NV、Standard BioTools Inc、乐普医疗科技北京有限公司、F. Hoffmann-La Roche Ltd、Bio-Rad Laboratories Inc 和 Agilent Technologies Inc.一些在亚太地区dPCR 和qPCR 市场营运的领先公司。

目录

第 1 章：简介

第 2 章：执行摘要

  • 重要见解

第 3 章：研究方法

  • 覆盖范围
  • 二次研究
  • 初步研究

第 4 章：亚太地区 dPCR 和 qPCR 市场 - 主要产业动态

  • 市场驱动因素
    • 遗传性疾病和传染病的发生率增加
    • 基因合成的投资和资金不断增加
    • PCR 技术的技术进步
  • 市场限制
    • PCR 系统成本高
    • 与 qPCR 相关的技术限制
  • 市场机会
    • 新兴国家越来越多地采用 PCR 方法
  • 未来的趋势
    • 微滴式数位PCR的发展
  • 影响分析：

第 5 章：dPCR 和 qPCR 市场 - 亚太市场分析

  • 亚太地区 dPCR 和 qPCR 市场收入，2022 - 2030

第 6 章：亚太地区 dPCR 和 qPCR 市场 - 收入和 2030 年预测 - 按治疗方式

  • 概述
  • 2022 年和 2030 年亚太地区 dPCR 和 qPCR 市场收入份额（按治疗方式）（%）
  • 定量PCR
  • 数位PCR

第 7 章：亚太地区 dPCR 和 qPCR 市场 - 收入和 2030 年预测 - 按产品

  • 概述
  • 2022 年和 2030 年亚太地区 dPCR 和 qPCR 市场收入份额（按产品）（%）
  • 试剂及耗材
  • 仪器
  • 软体与服务

第 8 章：亚太地区 dPCR 和 qPCR 市场 - 收入和 2030 年预测 - 按应用

  • 概述
  • 2022 年和 2030 年亚太地区 dPCR 和 qPCR 市场收入份额（按应用）（%）
  • 研究应用
  • 临床应用
  • 法医应用

第 9 章：亚太地区 dPCR 和 qPCR 市场 - 收入和 2030 年预测 - 按最终用户

  • 概述
  • 2022 年和 2030 年亚太地区 dPCR 和 qPCR 市场收入份额（按最终用户）（%）
  • 医院和诊断中心
  • 製药和生物技术公司
  • 研究实验室和学术机构
  • 法医实验室
  • 临床研究组织

第 10 章：亚太地区 dPCR 和 qPCR 市场 - 国家分析

    • 亚太地区 dPCR 和 qPCR 市场（依国家）
      • 中国
      • 日本
      • 印度
      • 澳洲
      • 韩国
      • 亚太地区其他地区

第 11 章：dPCR 与 qPCR 市场产业模式

  • 概述
  • 亚太地区 dPCR 和 qPCR 市场的成长策略
  • 有机成长策略
    • 概述
  • 无机成长策略
    • 概述

第 12 章：公司简介

  • Abbott Laboratories
  • Thermo Fisher Scientific Inc
  • Takara Bio Inc
  • Qiagen NV
  • Standard BioTools Inc
  • Lepu Medical Technology Beijing Co Ltd
  • F. Hoffmann-La Roche Ltd
  • Bio-Rad Laboratories Inc
  • Agilent Technologies Inc
  • Genome Diagnostics Pvt Ltd

第 13 章：附录

Product Code: BMIRE00029880

The Asia Pacific dPCR and qPCR market was valued at US$ 1,913.43 million in 2022 and is expected to reach US$ 4,139.50 million by 2030; it is estimated to grow at a CAGR of 10.1% from 2022 to 2030.

Technological Advancements in PCR Technologies Drive Asia Pacific dPCR and qPCR Market

Polymerase chain reaction (PCR) is a nearly ubiquitous, robust, and reliable technology used in most molecular biology labs to amplify specific stretches of DNA for genotyping, cloning, and analysis of single nucleotide variations and even serves as the basis for most next-generation sequencing (NGS) preparation. Technological advances are yielding different types of PCR techniques. The use of PCR technology has now been explored into several non-conventional applications, making molecular diagnosis easier and faster. In particular, advances in digital and real-time PCR are used to diagnose diseases, identify viruses and bacteria, and aid forensic investigations. Moreover, the researchers are trying to reduce test time using some nanomaterials. In March 2023, the Center for Augmented Safety System with Intelligence, Sensing of the Korea Institute of Science and Technology (KIST, President: Seok Jin Yoon) announced the development of an ultrafast PCR technology by Dr. Sang Kyung Kim (Director) and Dr. Seungwon Jung's research team. The ultrafast PCR reduces the test duration by ten times compared to the previous test by utilizing photothermal nanomaterials. The diagnostic performance of the new method is comparable to the current test method, and it can be finished in 5 minutes. Thus, technological advancements in PCR technologies propel the Asia Pacific dPCR and qPCR market growth.

Asia Pacific dPCR and qPCR Market Overview

The Asia Pacific dPCR and qPCR market in Asia Pacific is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. China, India and Japan are three major contributors to the growth of the market which is driven by increasing foreign direct investments in these countries, highly skilled, efficient and large number of labor, and streamlining government policies resulting in high investments for biotechnology sector. In addition, increasing cases of infectious and chronic diseases and government and non-government initiatives are also responsible for fueling the growth of the Asia Pacific dPCR and qPCR market.

Asia Pacific dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific dPCR and qPCR Market Segmentation

The Asia Pacific dPCR and qPCR market is segmented based on treatment, product, application, end user, and country.

Based on treatment, the Asia Pacific dPCR and qPCR market is bifurcated into quantitative PCR (qPCR) and digital PCR (dPCR). The digital PCR (dPCR) segment held a larger share in 2022.

By product, the Asia Pacific dPCR and qPCR market is segmented into reagents & consumables, instruments, and software & services. The reagents & consumables segment held the largest share in 2022.

By application, the Asia Pacific dPCR and qPCR market is research application, clinical application, and forensic application. The clinical application segment held the largest share in 2022. The clinical application segment is further subsegmented into oncology testing, blood screening, infectious disease testing, and other applications.

By end user, the Asia Pacific dPCR and qPCR market is segmented into hospitals and diagnostic centers, pharmaceutical and biotechnology companies, research laboratories and academic institutes, forensic laboratories, and clinical research organizations. The hospitals and diagnostic centers segment held the largest share in 2022.

Based on country, the Asia Pacific dPCR and qPCR market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific dPCR and qPCR market in 2022.

Abbott Laboratories, Thermo Fisher Scientific Inc, Takara Bio Inc, Genome Diagnostics Pvt Ltd, Qiagen NV, Standard BioTools Inc, Lepu Medical Technology Beijing Co Ltd, F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories Inc, and Agilent Technologies Inc are some of the leading companies operating in the Asia Pacific dPCR and qPCR market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Asia Pacific dPCR and qPCR Market - Key Industry Dynamics

  • 4.1 Market Drivers
    • 4.1.1 Increasing Incidence of Genetic and Infectious Diseases
    • 4.1.2 Rising Investments and Funds for Gene Synthesis
    • 4.1.3 Technological Advancements in PCR Technologies
  • 4.2 Market Restraints
    • 4.2.1 High Costs of PCR Systems
    • 4.2.2 Technical Limitations Associated with qPCR
  • 4.3 Market Opportunities
    • 4.3.1 Growing Adoption of PCR Methods in Emerging Countries
  • 4.4 Future Trends
    • 4.4.1 Development of Droplet Digital PCR
  • 4.5 Impact Analysis:

5. dPCR and qPCR Market - Asia Pacific Market Analysis

  • 5.1 Asia Pacific dPCR and qPCR Market Revenue (US$ Mn), 2022 - 2030

6. Asia Pacific dPCR and qPCR Market - Revenue and Forecast to 2030 - by Treatment

  • 6.1 Overview
  • 6.2 Asia Pacific dPCR and qPCR Market Revenue Share, by Treatment, 2022 & 2030 (%)
  • 6.3 Quantitative PCR
    • 6.3.1 Overview
    • 6.3.2 Quantitative PCR: Asia Pacific dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.4 Digital PCR
    • 6.4.1 Overview
    • 6.4.2 Digital PCR: Asia Pacific dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)

7. Asia Pacific dPCR and qPCR Market - Revenue and Forecast to 2030 - by Product

  • 7.1 Overview
  • 7.2 Asia Pacific dPCR and qPCR Market Revenue Share, by Product, 2022 & 2030 (%)
  • 7.3 Reagents & Consumables
    • 7.3.1 Overview
    • 7.3.2 Reagents & Consumables: Asia Pacific dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Instruments
    • 7.4.1 Overview
    • 7.4.2 Instruments: Asia Pacific dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Software & Services
    • 7.5.1 Overview
    • 7.5.2 Software & Services: Asia Pacific dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)

8. Asia Pacific dPCR and qPCR Market - Revenue and Forecast to 2030 - by Application

  • 8.1 Overview
  • 8.2 Asia Pacific dPCR and qPCR Market Revenue Share, by Application, 2022 & 2030 (%)
  • 8.3 Research Application
    • 8.3.1 Overview
    • 8.3.2 Research Application: Asia Pacific dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Clinical Application
    • 8.4.1 Overview
    • 8.4.2 Clinical Application: Asia Pacific dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
      • 8.4.2.1 Asia Pacific dPCR and qPCR Market, by Clinical Application, 2020-2030 (US$ Million)
  • 8.5 Forensic Application
    • 8.5.1 Overview
    • 8.5.2 Forensic Application: Asia Pacific dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)

9. Asia Pacific dPCR and qPCR Market - Revenue and Forecast to 2030 - by End-User

  • 9.1 Overview
  • 9.2 Asia Pacific dPCR and qPCR Market Revenue Share, by End-User, 2022 & 2030 (%)
  • 9.3 Hospitals and Diagnostic Centers
    • 9.3.1 Overview
    • 9.3.2 Hospitals and Diagnostic Centers: Asia Pacific dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Pharmaceutical and Biotechnology Companies
    • 9.4.1 Overview
    • 9.4.2 Pharmaceutical and Biotechnology Companies: Asia Pacific dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.5 Research Laboratories and Academic Institutes
    • 9.5.1 Overview
    • 9.5.2 Research Laboratories and Academic Institutes: Asia Pacific dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.6 Forensic Laboratories
    • 9.6.1 Overview
    • 9.6.2 Forensic Laboratories: Asia Pacific dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.7 Clinical Research Organizations
    • 9.7.1 Overview
    • 9.7.2 Clinical Research Organizations: Asia Pacific dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)

10. Asia Pacific dPCR and qPCR Market - Country Analysis

    • 10.1.1 Asia Pacific dPCR and qPCR Market, by Country
      • 10.1.1.1 China
        • 10.1.1.1.1 China: Asia Pacific dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.1.2 China: Asia Pacific dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 10.1.1.1.3 China: Asia Pacific dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 10.1.1.1.4 China: Asia Pacific dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 10.1.1.1.4.1 China: Asia Pacific dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 10.1.1.1.5 China: Asia Pacific dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
      • 10.1.1.2 Japan
        • 10.1.1.2.1 Japan: Asia Pacific dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.2.2 Japan: Asia Pacific dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 10.1.1.2.3 Japan: Asia Pacific dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 10.1.1.2.4 Japan: Asia Pacific dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 10.1.1.2.4.1 Japan: Asia Pacific dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 10.1.1.2.5 Japan: Asia Pacific dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
      • 10.1.1.3 India
        • 10.1.1.3.1 India: Asia Pacific dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.3.2 India: Asia Pacific dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 10.1.1.3.3 India: Asia Pacific dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 10.1.1.3.4 India: Asia Pacific dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 10.1.1.3.4.1 India: Asia Pacific dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 10.1.1.3.5 India: Asia Pacific dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
      • 10.1.1.4 Australia
        • 10.1.1.4.1 Australia: Asia Pacific dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.4.2 Australia: Asia Pacific dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 10.1.1.4.3 Australia: Asia Pacific dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 10.1.1.4.4 Australia: Asia Pacific dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 10.1.1.4.4.1 Australia: Asia Pacific dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 10.1.1.4.5 Australia: Asia Pacific dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
      • 10.1.1.5 South Korea
        • 10.1.1.5.1 South Korea: Asia Pacific dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.5.2 South Korea: Asia Pacific dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 10.1.1.5.3 South Korea: Asia Pacific dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 10.1.1.5.4 South Korea: Asia Pacific dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 10.1.1.5.4.1 South Korea: Asia Pacific dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 10.1.1.5.5 South Korea: Asia Pacific dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
      • 10.1.1.6 Rest of Asia Pacific
        • 10.1.1.6.1 Rest of Asia Pacific: Asia Pacific dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.6.2 Rest of Asia Pacific: Asia Pacific dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 10.1.1.6.3 Rest of Asia Pacific: Asia Pacific dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 10.1.1.6.4 Rest of Asia Pacific: Asia Pacific dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 10.1.1.6.4.1 Rest of Asia Pacific: Asia Pacific dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 10.1.1.6.5 Rest of Asia Pacific: Asia Pacific dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)

11. dPCR and qPCR Market-Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in Asia Pacific dPCR and qPCR Market
  • 11.3 Organic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Inorganic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Abbott Laboratories
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Thermo Fisher Scientific Inc
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Takara Bio Inc
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Qiagen NV
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Standard BioTools Inc
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Lepu Medical Technology Beijing Co Ltd
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 F. Hoffmann-La Roche Ltd
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Bio-Rad Laboratories Inc
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Agilent Technologies Inc
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 Genome Diagnostics Pvt Ltd
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments

13. Appendix

  • 13.1 About Us
  • 13.2 Glossary of Terms

List Of Tables

  • Table 1. Asia Pacific dPCR and qPCR Market Segmentation
  • Table 2. Asia Pacific dPCR and qPCR Market, by Clinical Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 3. China: Asia Pacific dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 4. China: Asia Pacific dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 5. China: Asia Pacific dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 6. China: Asia Pacific dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 7. China: Asia Pacific dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 8. Japan: Asia Pacific dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 9. Japan: Asia Pacific dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 10. Japan: Asia Pacific dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 11. Japan: Asia Pacific dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 12. Japan: Asia Pacific dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 13. India: Asia Pacific dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 14. India: Asia Pacific dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 15. India: Asia Pacific dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 16. India: Asia Pacific dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 17. India: Asia Pacific dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 18. Australia: Asia Pacific dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 19. Australia: Asia Pacific dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 20. Australia: Asia Pacific dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 21. Australia: Asia Pacific dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 22. Australia: Asia Pacific dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 23. South Korea: Asia Pacific dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 24. South Korea: Asia Pacific dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 25. South Korea: Asia Pacific dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 26. South Korea: Asia Pacific dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 27. South Korea: Asia Pacific dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 28. Rest of Asia Pacific: Asia Pacific dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 29. Rest of Asia Pacific: Asia Pacific dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 30. Rest of Asia Pacific: Asia Pacific dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 31. Rest of Asia Pacific: Asia Pacific dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 32. Rest of Asia Pacific: Asia Pacific dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 33. Recent Organic Growth Strategies in Asia Pacific dPCR and qPCR Market
  • Table 34. Recent Inorganic Growth Strategies in the Asia Pacific dPCR and qPCR Market
  • Table 35. Glossary of Terms, Asia Pacific dPCR and qPCR Market

List Of Figures

  • Figure 1. Asia Pacific dPCR and qPCR Market Segmentation, By Country
  • Figure 2. Asia Pacific dPCR and qPCR Market - Key Industry Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Asia Pacific dPCR and qPCR Market Revenue (US$ Mn), 2022 - 2030
  • Figure 5. Asia Pacific dPCR and qPCR Market Revenue Share, by Treatment, 2022 & 2030 (%)
  • Figure 6. Quantitative PCR: Asia Pacific dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 7. Digital PCR: Asia Pacific dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Asia Pacific dPCR and qPCR Market Revenue Share, by Product, 2022 & 2030 (%)
  • Figure 9. Reagents & Consumables: Asia Pacific dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Instruments: Asia Pacific dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Software & Services: Asia Pacific dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Asia Pacific dPCR and qPCR Market Revenue Share, by Application, 2022 & 2030 (%)
  • Figure 13. Research Application: Asia Pacific dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Clinical Application: Asia Pacific dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Forensic Application: Asia Pacific dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Asia Pacific dPCR and qPCR Market Revenue Share, by End-User, 2022 & 2030 (%)
  • Figure 17. Hospitals and Diagnostic Centers: Asia Pacific dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Pharmaceutical and Biotechnology Companies: Asia Pacific dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Research Laboratories and Academic Institutes: Asia Pacific dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Forensic Laboratories: Asia Pacific dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Clinical Research Organizations: Asia Pacific dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Asia Pacific dPCR and qPCR Market, by Key Country - Revenue, 2022 (US$ Million)
  • Figure 23. Asia Pacific dPCR and qPCR Market, By Key Countries, 2022 and 2030 (%)
  • Figure 24. China: Asia Pacific dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 25. Japan: Asia Pacific dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 26. India: Asia Pacific dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 27. Australia: Asia Pacific dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 28. South Korea: Asia Pacific dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 29. Rest of Asia Pacific: Asia Pacific dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 30. Growth Strategies in Asia Pacific dPCR and qPCR Market